These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Search MEDLINE/PubMed


  • Title: [PreS1 Antigen of HBV Down-Regulates MHC-Ⅰ on the Surface of Hepatocytes and Promotes Hepatocarcinogenesis].
    Author: Rao JJ, Zeng F, Ji MS, Xu X, Yu CF, Yang J, Liu L, Liu ZX.
    Journal: Sichuan Da Xue Xue Bao Yi Xue Ban; 2022 Mar; 53(2):285-290. PubMed ID: 35332731.
    Abstract:
    OBJECTIVE: To explore the internal mechanism of hepatocellular carcinoma (HCC) induced by chronic hepatitis B virus (HBV) infection. METHODS: L02, HepG2 and Huh7 cells stably overexpressing HBV preS1 antigen were analyzed by flow cytometry, qRT-PCR and tumorigenesis in nude mice to evaluate the effect of preS1 antigen in HBV-related hepatocarcinogenesis. RESULTS: Our results showed that the expression of cancer stem cell (CSCs) related factors and cell surface markers in preS1 overexpressing cells were up-regulated, and the tumorigenicity of these cells was enhanced in nude mice. In addition, preS1 overexpression could down-regulate the expression of major histocompatibility complex Ⅰ (MHC-Ⅰ). The expression of MHC-Ⅰ on the cell surface could be restored by adding interferon gamma (IFN-γ) in the process of cell culturing and the tumorigenicity of cells in nude mice could thus be reduced. CONCLUSION: Based on the above results, we believe that preS1 is a carcinogen of HBV and that it promotes the formation of liver cancer through down regulating MHC-Ⅰ on the surface of hepatocytes. 目的: 探讨慢性乙型肝炎病毒(HBV)感染诱发肝癌所涉及的内在机制。 方法: 对稳定过表达HBV前S1抗原(preS1)的L02、HepG2和Huh7细胞进行流式细胞术、实时荧光定量和裸鼠成瘤等实验来评估preS1在HBV相关性肝癌发生中的作用。 结果: preS1诱导细胞肿瘤干细胞(CSCs)相关因子和表面标志分子的表达上调,增强细胞的裸鼠成瘤能力;过表达preS1可以下调细胞表面组织相容性复合体Ⅰ(MHC-Ⅰ)的表达;在细胞培养过程中加入γ干扰素(IFN-γ)可以恢复细胞表面MHC-Ⅰ的表达,降低细胞的裸鼠成瘤能力。 结论: preS1是HBV的一个致癌因子,通过下调肝细胞表面MHC I促进肝癌产生。
    [Abstract] [Full Text] [Related] [New Search]